Literature DB >> 20855588

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.

Takahiro Horie1, Koh Ono, Masahito Horiguchi, Hitoo Nishi, Tomoyuki Nakamura, Kazuya Nagao, Minako Kinoshita, Yasuhide Kuwabara, Hiroyuki Marusawa, Yoshitaka Iwanaga, Koji Hasegawa, Masayuki Yokode, Takeshi Kimura, Toru Kita.   

Abstract

Sterol regulatory element-binding protein 2 (SREBP-2) transcription factor has been identified as a key protein in cholesterol metabolism through the transactivation of the LDL receptor and cholesterol biosynthesis genes. Here, we generated mice lacking microRNA (miR)-33, encoded by an intron of the Srebp2, and showed that miR-33 repressed the expression of ATP-binding cassette transporter A1 (ABCA1) protein, a key regulator of HDL synthesis by mediating cholesterol efflux from cells to apolipoprotein A (apoA)-I. In fact, peritoneal macrophages derived from miR-33-deficient mice showed a marked increase in ABCA1 levels and higher apoA-I-dependent cholesterol efflux than those from WT mice. ABCA1 protein levels in liver were also higher in miR-33-deficient mice than in WT mice. Moreover, miR-33-deficient mice had significantly higher serum HDL cholesterol levels than WT mice. These data establish a critical role for miR-33 in the regulation of ABCA1 expression and HDL biogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855588      PMCID: PMC2951399          DOI: 10.1073/pnas.1008499107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Recombineering: a powerful new tool for mouse functional genomics.

Authors:  N G Copeland; N A Jenkins; D L Court
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

2.  Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport.

Authors:  Z Zhang; S Yamashita; K Hirano; Y Nakagawa-Toyama; A Matsuyama; M Nishida; N Sakai; M Fukasawa; H Arai; J Miyagawa; Y Matsuzawa
Journal:  Atherosclerosis       Date:  2001-11       Impact factor: 5.162

3.  Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1.

Authors:  Yutong Wang; John F Oram
Journal:  J Biol Chem       Date:  2001-12-12       Impact factor: 5.157

Review 4.  Structure, function and regulation of the ABC1 gene product.

Authors:  G Schmitz; T Langmann
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

5.  ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.

Authors:  B L Vaisman; G Lambert; M Amar; C Joyce; T Ito; R D Shamburek; W J Cain; J Fruchart-Najib; E D Neufeld; A T Remaley; H B Brewer; S Santamarina-Fojo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

6.  miR-33 links SREBP-2 induction to repression of sterol transporters.

Authors:  Tyler J Marquart; Ryan M Allen; Daniel S Ory; Angel Baldán
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 7.  Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency.

Authors:  M R Hayden; S M Clee; A Brooks-Wilson; J Genest; A Attie; J J Kastelein
Journal:  Curr Opin Lipidol       Date:  2000-04       Impact factor: 4.776

8.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Authors:  S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC.

Authors:  Shinichi Usui; Yukichi Hara; Seijin Hosaki; Mitsuyo Okazaki
Journal:  J Lipid Res       Date:  2002-05       Impact factor: 5.922

10.  Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations.

Authors:  Federica Basso; Lita Freeman; Catherine L Knapper; Alan Remaley; John Stonik; Edward B Neufeld; Terese Tansey; Marcelo J A Amar; Jamila Fruchart-Najib; Nicholas Duverger; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Lipid Res       Date:  2002-11-04       Impact factor: 5.922

View more
  174 in total

Review 1.  Genetics of cholesterol efflux.

Authors:  Iulia Iatan; Aurélien Palmyre; Sarah Alrasheed; Isabelle Ruel; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism.

Authors:  Waqar Arif; Gandhar Datar; Auinash Kalsotra
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-11       Impact factor: 4.490

Review 3.  MicroRNAs regulating lipid metabolism in atherogenesis.

Authors:  K J Rayner; C Fernandez-Hernando; K J Moore
Journal:  Thromb Haemost       Date:  2012-01-25       Impact factor: 5.249

Review 4.  Regulation of cholesterol homeostasis.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

5.  Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production.

Authors:  Ping-Chih Ho; Kun-Che Chang; Ya-Shan Chuang; Li-Na Wei
Journal:  FASEB J       Date:  2011-02-01       Impact factor: 5.191

Review 6.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 7.  Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism.

Authors:  Ángel Baldán; Carlos Fernández-Hernando
Journal:  Curr Opin Lipidol       Date:  2016-12       Impact factor: 4.776

Review 8.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

9.  Human MicroRNA-33b Promotes Atherosclerosis in Apoe-/- Mice.

Authors:  M Mahmood Hussain; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 10.  The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.